To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0955 | Betaxolol |
Selective beta-1 adrenergic receptor antagonist with antihypertensive and anti-glaucoma activities and devoid of intrinsic sympathomimetic activity
More description
|
|
| DCC0954 | Beta-nor-lapachone |
Natural antibiofilm agent and adjuvant on the antifungal therapy related to resistant infections caused by C. glabrata
More description
|
|
| DCC0953 | Beta-erythroidine Hcl |
Phytoestrogen, possessing typical curare-like action
More description
|
|
| DCC0952 | Beta-cit-fp |
Potent ligand of the serotonin (5-HT) and dopamine (DA) transporters used in diagonisis of Parkinson's disease as SPECT imaging precursor
More description
|
|
| DCC0951 | Beta-blocker-15 |
Novel negative allosteric modulator of the ß2-adrenergic receptor (ß2AR), inhibiting cAMP production through the ß2AR, but not that mediated by other Gs-coupled receptors, also inhibiting ß-arrestin recruitment to the activated ß2AR
More description
|
|
| DCC0950 | Berotralstat Hydrochloride |
Novel selective inhibitor of plasma kallikrein, blocking the enzymatic activity of plasma kallikrein in releasing bradykinin, the major biologic peptide that promotes swelling and pain associated with attacks of HAE
More description
|
|
| DCC0949 | Berotralstat Analog |
Novel inhibitor of plasma kallikrein
More description
|
|
| DCC0948 | Berberine-ornidazole |
Novel antibacterial agent against multidrug-resistant Escherichia coli at low concentrations as 0.007 mM, disintegrating membrane, accelerating ROS accumulation, reducing bacterial metabolism, and intercalating into DNA groove
More description
|
|
| DCC0947 | Berberine-benzothiazole-2-thiol |
Novel antibacterial agent against multidrug-resistant Escherichia coli at low concentrations as 0.007 mM, disintegrating membrane, accelerating ROS accumulation, reducing bacterial metabolism, and intercalating into DNA groove
More description
|
|
| DCC0946 | Bepridil |
Long-acting calcium-blocking agent with significant anti-anginal activity
More description
|
|
| DCC0945 | Benzyl Vinyl Carbonate |
Useful pharmaceutical building block
More description
|
|
| DCC0944 | Benzphetamine Hydrochloride |
Anorectic, primarily promoting weight loss through reduced appetite
More description
|
|
| DCC0943 | Benzobicyclon |
Inhibitor of 4-hydroxyphenylpyruvate dioxygenase (HPPD), acting as a herbicide
More description
|
|
| DCC0942 | Benzavir-1 |
anti-HSV agent
More description
|
|
| DCC0941 | Benperidol Hydrochloride |
Potent D2/D4 dopamine receptor antagonist, neuroleptic and antipsychotic
More description
|
|
| DCC0940 | Benorterone |
Antiandrogen, being effective in the treatment of acne, seborrhea, and hirsutism in women
More description
|
|
| DCC0939 | Benmoxin |
Irreversible and nonselective Monoamine_oxidase_inhibitor>monoamine oxidase inhibitor (MAOI)
More description
|
|
| DCC0938 | Benfluron Hydrochloride |
Novel inhibitor of HIV-1 Rev function, also acting as a cytostatic agent with substantial antiretroviral activity
More description
|
|
| DCC0937 | Benc-511 |
Novel potent PI3K inhibitor, suppressing metastasis of non-small cell lung cancer cells by modulating β-catenin/ZEB1 regulatory loop, blocking AKT phosphorylation
More description
|
|
| DCC0936 | Benazepril |
Inhibitor of angiotensin-converting enzyme (ACE); Prodrug of benazeprilat
More description
|
|
| DCC0935 | Benanserin Hydrochloride |
Inhibitor of monoamine oxidase; Anti-serotonin agent
More description
|
|
| DCC0934 | Bemppox |
Novel potent and specific inhibitor of dog gastric lipase (DGL)
More description
|
|
| DCC0933 | Behenyl Palmitate |
Fatty Ester for Lipid Research
More description
|
|
| DCC0932 | beclomethasone 17-monopropionate |
Active metabolite of beclomethasone dipropionate
More description
|
|
| DCC0931 | Bdoia383 |
Novel CBP/p300 Bromodomains inhibitor, binding BRD4 almost identical to SGC-CBP30
More description
|
|
| DCC0930 | Bdm41906 |
Novel specific bona fide EthR-inhibitor, boosting ETH 4 times in an intravenously infected TB mice model
More description
|
|
| DCC0929 | Bdm31827 |
Novel EthR inhibitor and ethionamide booster
More description
|
|
| DCC0928 | Bdm31369 |
Novel activator of ethionamide
More description
|
|
| DCC0927 | Bdm31343 |
Novel EthR inhibitor, boosting antituberculous activity of ethionamide
More description
|
|
| DCC0926 | Bdm14471 |
Potent and selective hydroxamate PfAM1 inhibitor
More description
|
|